Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for ArQule, Inc. (ARQL)

« Back to company index

ARQL Chatter Timeline

Stock Ticker for ARQL

Most Active Tweeters for ARQL

UserTweets
@jfais20 2
@gcbioinv 1
@voxexnihilo 1
@cdespinoza1 1

Recent Tweets for ARQL

cdespinoza1 @cdespinoza1
@iamjohn_c Nice! Just remember the $ARQL deal was announced as the results of Phase 1 for ARQ531 were released. Als… https://t.co/Q4Q11ubLMh
July 11th 2020, 6:07pm
voxexnihilo @voxexnihilo
RT @jfais20: $APTO new presentation slides up (thanks WellsG)- important to note like $ARQL, CG-806 trial allows for intrapatient dose esca…
July 10th 2020, 2:07pm
jfais20 @jfais20
$APTO new presentation slides up (thanks WellsG)- important to note like $ARQL, CG-806 trial allows for intrapatien… https://t.co/kyfesodao4
July 10th 2020, 11:07am
gcbioinv @gcbioinv
An interesting story told by former $ARQL CFO Marc Schegerin, formerly program director at $BIIB for Aducanumab Th… https://t.co/IYObQXmtxB
July 8th 2020, 7:07am
jfais20 @jfais20
@SettleWilliam we might have to wait until ASH, but there is a chance they pull an $ARQL and disclose initial respo… https://t.co/CounhEnFDr
July 7th 2020, 7:07pm
ThirdEyeTobias @ThirdEyeTobias
@QuailTrading @Matthew_Hibbing $ARQL was around $10 right before it was acquired. https://t.co/zeCWgdkQ6o
June 28th 2020, 3:06pm
QuailTrading @QuailTrading
@Matthew_Hibbing Any idea what $ARQL price was prior to the buyout? https://t.co/bvV0UPWmss
June 28th 2020, 2:06pm
GantosJ @GantosJ
@JacobPlieth @mergerfollower At EHA $APTO has only full dose Level-3 Let me remind you, $ARQL saw complete inhibit… https://t.co/ixziXKm4S6
June 23rd 2020, 10:06am
grpetersen1 @grpetersen1
RT @ej23ny: $atnm to be honest I never considered HC Wainwright price target but think about it $arql was acquired for 2.8B based on phas…
June 17th 2020, 9:06pm
ej23ny @ej23ny
$atnm to be honest I never considered HC Wainwright price target but think about it $arql was acquired for 2.8B b… https://t.co/6TFN9We2n5
June 17th 2020, 11:06am
gcbioinv @gcbioinv
@adamfeuerstein Aren't back from the dead stories the most interesting? $ARQL $BLU come to mind
June 16th 2020, 8:06am
Gambiste1 @Gambiste1
RT @GantosJ: @FinanceBubble $ARQL's ARQ 531 in B-cell malignancies, was in phase-1 the same as $APTO
June 15th 2020, 9:06pm
GantosJ @GantosJ
@FinanceBubble $ARQL's ARQ 531 in B-cell malignancies, was in phase-1 the same as $APTO
June 15th 2020, 8:06pm
GypsyDRB @GypsyDRB
RT @GantosJ: The market is looking already for PR-Partial Response in $APTO's trial! But they forgot how long it took $ARQL & other BTK stu…
June 12th 2020, 11:06am
GantosJ @GantosJ
The market is looking already for PR-Partial Response in $APTO's trial! But they forgot how long it took $ARQL & ot… https://t.co/RtlygSnYGB
June 12th 2020, 11:06am
GantosJ @GantosJ
$ARQL's ARQ-531 start showing responses after a few scans of the recommended dose and I think CG-806 will follow th… https://t.co/b8UlML6n9O
June 12th 2020, 11:06am
DeschainGs @DeschainGs
RT @mtheory11bio: I’d love to see $APTO present ~ 1.4 to 1.6 micromolar of CG-806 in the 600mg patients at EHA later this week. $ARQL was…
June 11th 2020, 6:06pm
jrock452 @jrock452
@NickBiotech @GantosJ Just need to have patience if you want to see $arql part 2 .
June 3rd 2020, 12:06pm
cpowerfitness @cpowerfitness
RT @TradingTrooper: $SONO just hit a fresh HOD, +19%. Stock and option action giving me flashbacks to $ARQL.. (which bricked)
May 21st 2020, 2:05pm
TradingTrooper @TradingTrooper
$SONO just hit a fresh HOD, +19%. Stock and option action giving me flashbacks to $ARQL.. (which bricked) https://t.co/x0CJth4PKq
May 21st 2020, 2:05pm
Kevvy_Kaye @Kevvy_Kaye
@Pharmdca @semodough For a double? How bout when I was pding the table on $ARQL at $3.
May 20th 2020, 4:05pm
TradeTexasBig @TradeTexasBig
RT @gcbioinv: Sighted at the grocery store $ARQL https://t.co/OdBI1MqYh4
May 16th 2020, 2:05pm
gcbioinv @gcbioinv
Sighted at the grocery store $ARQL https://t.co/OdBI1MqYh4
May 16th 2020, 1:05pm
XBIObserver @XBIObserver
@GantosJ @cashbiotech Well, if the MYC candidate adds value, I'd like to see it fetch more than $ARQL. Heck look w… https://t.co/WXpJPWsmZY
May 13th 2020, 3:05pm
cashbiotech @cashbiotech
@GantosJ @XBIObserver Wow! And correct me if I’m wrong... at the time of BO $arql candidate ARQ 531 was being evalu… https://t.co/pXOlrNOwcG
May 13th 2020, 3:05pm
GantosJ @GantosJ
@cashbiotech @XBIObserver I will make it easier for you, just check out how much $MRK paid for $ARQL 6 months ago,… https://t.co/vcvvNrLTte
May 13th 2020, 3:05pm
jrock452 @jrock452
$APTO-- $arql part 2 in the works
May 11th 2020, 10:05am
lblegend33 @lblegend33
@Biohazard3737 $Apto could be $arql part 2 bud
May 7th 2020, 8:05pm
Biohazard3737 @Biohazard3737
Unfortunately, I didn’t stick with $ARQL, because it had „gone up too much“ and instead doubled down on $SNSS, thi… https://t.co/GPQMgQmtu1
May 7th 2020, 8:05pm
monroewarriors5 @monroewarriors5
@haodongvli Buyout on the same day as data release would be perfect just like $ARQL
April 24th 2020, 11:04am
gcbioinv @gcbioinv
@Biohazard3737 Like the same kind of target engagement claim made by $SNSS $ARQL etc that actually was off in human… https://t.co/DS3FbYoPJM
April 23rd 2020, 11:04am
gcbioinv @gcbioinv
$MRK has assigned new MK- designations to $ARQL drugs ARQ-531 -> MK-1026 ARQ-092 -> MK-7075 Haven't seen a new name for ARQ-751 yet
April 20th 2020, 10:04am
scottsherman @scottsherman
@patrick03704225 Look up the $ARQL history.
April 16th 2020, 3:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.